Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

Market Cap	8.32B
Revenue (ttm)	3.97B
Net Income (ttm)	235.20M
Shares Out	1.02B
EPS (ttm)	0.23
PE Ratio	35.55
Forward PE	27.80
Dividend	0.12 (1.48%)
Ex-Dividend Date	n/a

Volume	13,393,015
Average Volume	29,445,243
Open	8.26
Previous Close	8.30
Day's Range	8.23 - 8.35
52-Week Range	5.74 - 9.42
Beta	1.75
RSI	46.01
Earnings Date	Aug 22, 2025

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the production and sales of pharmaceuticals, raw materials, and additives in China. The company is involved in cosmetics and medicine businesses. It produces cleansers, lotions, creams, essences, masks, and other products. In addition, the company offers dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, and accelerates project research and investigation areas. It serves hospitals, primary medical institutions, and chain drug stores, etc. The company was formerly known as Lushan...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1993
• Employees: 3,630
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600223

Financial Performance

In 2024, SHA:600223's revenue was 3.98 billion, a decrease of -13.02% compared to the previous year's 4.58 billion. Earnings were 243.53 million, a decrease of -19.73%.